Evidence of inappropriate application of autologous cartilage transplantation therapy in an uncontrolled environment

Michael A. Mont, Lynne C Jones, Barry N. Vogelstein, David S. Hungerford

Research output: Contribution to journalArticle

Abstract

Autologous chondrocyte transplantation is a new procedure developed for the treatment of focal articular cartilage defects of the knee. The exact indications and limitations of this procedure have not yet been completely defined through prospective, randomized studies. The purpose of this study was to examine the indications and contraindications for surgery in consecutive cases initially rejected for reimbursement of surgical expenses by insurance companies, but now on appeal, to assess whether patients referred by the physicians met the procedure criteria. Twenty-four consecutive candidates were referred for adjudication when the recommending orthopaedic surgeon appealed a rejection by a medical reviewer. The factors examined included the number and size of the cartilage lesions, the presence of tricompartmental arthritis, transplantation proposed for patellar lesions, patient age, and sagittal plane deformity. In 23 of 24 cases (96%) the indications for the procedure were not met or specific contraindications were present. In 15 of 24 cases (63%) there were multi pie contraindications. The results of this study underscore the importance of controlled, application- limited experience before the release of new procedures for widespread clinical applications. The uncontrolled use of this procedure may negatively skew the overall results for this technique, prejudicing a procedure that may be successful for the correct indications.

Original languageEnglish (US)
Pages (from-to)617-620
Number of pages4
JournalAmerican Journal of Sports Medicine
Volume27
Issue number5
StatePublished - 1999

Fingerprint

Autologous Transplantation
Cartilage
Surgical Insurance
Therapeutics
Articular Cartilage
Chondrocytes
Arthritis
Knee
Transplantation
Prospective Studies
Physicians

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Evidence of inappropriate application of autologous cartilage transplantation therapy in an uncontrolled environment. / Mont, Michael A.; Jones, Lynne C; Vogelstein, Barry N.; Hungerford, David S.

In: American Journal of Sports Medicine, Vol. 27, No. 5, 1999, p. 617-620.

Research output: Contribution to journalArticle

@article{657897d34ed04c7bbdd870036e8074ce,
title = "Evidence of inappropriate application of autologous cartilage transplantation therapy in an uncontrolled environment",
abstract = "Autologous chondrocyte transplantation is a new procedure developed for the treatment of focal articular cartilage defects of the knee. The exact indications and limitations of this procedure have not yet been completely defined through prospective, randomized studies. The purpose of this study was to examine the indications and contraindications for surgery in consecutive cases initially rejected for reimbursement of surgical expenses by insurance companies, but now on appeal, to assess whether patients referred by the physicians met the procedure criteria. Twenty-four consecutive candidates were referred for adjudication when the recommending orthopaedic surgeon appealed a rejection by a medical reviewer. The factors examined included the number and size of the cartilage lesions, the presence of tricompartmental arthritis, transplantation proposed for patellar lesions, patient age, and sagittal plane deformity. In 23 of 24 cases (96{\%}) the indications for the procedure were not met or specific contraindications were present. In 15 of 24 cases (63{\%}) there were multi pie contraindications. The results of this study underscore the importance of controlled, application- limited experience before the release of new procedures for widespread clinical applications. The uncontrolled use of this procedure may negatively skew the overall results for this technique, prejudicing a procedure that may be successful for the correct indications.",
author = "Mont, {Michael A.} and Jones, {Lynne C} and Vogelstein, {Barry N.} and Hungerford, {David S.}",
year = "1999",
language = "English (US)",
volume = "27",
pages = "617--620",
journal = "American Journal of Sports Medicine",
issn = "0363-5465",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Evidence of inappropriate application of autologous cartilage transplantation therapy in an uncontrolled environment

AU - Mont, Michael A.

AU - Jones, Lynne C

AU - Vogelstein, Barry N.

AU - Hungerford, David S.

PY - 1999

Y1 - 1999

N2 - Autologous chondrocyte transplantation is a new procedure developed for the treatment of focal articular cartilage defects of the knee. The exact indications and limitations of this procedure have not yet been completely defined through prospective, randomized studies. The purpose of this study was to examine the indications and contraindications for surgery in consecutive cases initially rejected for reimbursement of surgical expenses by insurance companies, but now on appeal, to assess whether patients referred by the physicians met the procedure criteria. Twenty-four consecutive candidates were referred for adjudication when the recommending orthopaedic surgeon appealed a rejection by a medical reviewer. The factors examined included the number and size of the cartilage lesions, the presence of tricompartmental arthritis, transplantation proposed for patellar lesions, patient age, and sagittal plane deformity. In 23 of 24 cases (96%) the indications for the procedure were not met or specific contraindications were present. In 15 of 24 cases (63%) there were multi pie contraindications. The results of this study underscore the importance of controlled, application- limited experience before the release of new procedures for widespread clinical applications. The uncontrolled use of this procedure may negatively skew the overall results for this technique, prejudicing a procedure that may be successful for the correct indications.

AB - Autologous chondrocyte transplantation is a new procedure developed for the treatment of focal articular cartilage defects of the knee. The exact indications and limitations of this procedure have not yet been completely defined through prospective, randomized studies. The purpose of this study was to examine the indications and contraindications for surgery in consecutive cases initially rejected for reimbursement of surgical expenses by insurance companies, but now on appeal, to assess whether patients referred by the physicians met the procedure criteria. Twenty-four consecutive candidates were referred for adjudication when the recommending orthopaedic surgeon appealed a rejection by a medical reviewer. The factors examined included the number and size of the cartilage lesions, the presence of tricompartmental arthritis, transplantation proposed for patellar lesions, patient age, and sagittal plane deformity. In 23 of 24 cases (96%) the indications for the procedure were not met or specific contraindications were present. In 15 of 24 cases (63%) there were multi pie contraindications. The results of this study underscore the importance of controlled, application- limited experience before the release of new procedures for widespread clinical applications. The uncontrolled use of this procedure may negatively skew the overall results for this technique, prejudicing a procedure that may be successful for the correct indications.

UR - http://www.scopus.com/inward/record.url?scp=0032876405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032876405&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 617

EP - 620

JO - American Journal of Sports Medicine

JF - American Journal of Sports Medicine

SN - 0363-5465

IS - 5

ER -